http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101886983-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-66 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-46 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2012-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101886983-B1 |
| titleOfInvention | Fc-free antibodies comprising two fab fragments and methods of use |
| abstract | The invention encompasses a bispecific antibody comprising two or more of the following fab fragments, wherein the Fc domain is absent, wherein the first Fab fragment comprises at least one antigen binding site specific for the first antigen; The second Fab fragment comprises at least one antigen binding site specific for the second antigen, wherein the variable or constant region of the second Fab heavy and light chain is replaced by an exchanged bispecific antibody; Its preparation, pharmaceutical compositions comprising said antibodies, and uses thereof. |
| priorityDate | 2011-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1070.